☆ 4.5 Letter

dsDNA from extracellular vesicles (EVs) in adult AML

ANNALS OF HEMATOLOGY (2021)

Journal

ANNALS OF HEMATOLOGY

Volume 100, Issue 5, Pages 1355-1356

Publisher

SPRINGER

DOI: 10.1007/s00277-020-04109-z

Keywords

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Potential Protective Role of Melatonin in Benign Mammary Cells Reprogrammed by Extracellular Vesicles from Malignant Cells

Caroline Procopio de Oliveira, Barbara Maria Frigieri, Heidge Fukumasu, Luiz Gustavo de Almeida Chuffa, Adriana Alonso Novais, Debora Aparecida Pires de Campos Zuccari

Summary: Melatonin shows a protective effect in the clinical treatment of canine mammary tumors by modulating EV-mediated signaling.

BIOMEDICINES (2023)

Add to Collection

Review Engineering, Biomedical

From Conventional to Microfluidic: Progress in Extracellular Vesicle Separation and Individual Characterization

Mingrui Chen, Shujing Lin, Cheng Zhou, Daxiang Cui, Hossam Haick, Ning Tang

Summary: Extracellular vesicles (EVs) are membrane vesicles containing various cargo, and they show promise as biomarkers for disease diagnosis and therapy. However, their use in personalized healthcare is limited by their heterogeneity and isolation difficulties. To address this challenge, microfluidic platforms are being explored for single-particle level characterization of EVs. This review discusses the biogenesis and heterogeneity of EVs, and provides an overview on the advances in microfluidics-based research for EV separation and single EV characterization. It also highlights the potential of combining microfluidics with artificial intelligence (AI) for single EV analysis and precision medicine applications.

ADVANCED HEALTHCARE MATERIALS (2023)

Add to Collection

Review Endocrinology & Metabolism

Extracellular vesicles derived from different sources play various roles in diabetic retinopathy

Tingting Chen, Fang Wang, Jiayi Wei, Le Feng

Summary: Extracellular vesicles (EVs) are secreted by almost all cell types and present in almost all biological fluids. They have been found to have potential roles in the diagnosis and treatment of diabetic retinopathy (DR). Changes in EVs' quantity and content can function as biomarkers for the pathological status of DR, such as inflammation, neovascularization, and epithelial-mesenchymal transition. In addition, as natural, safe, and efficient drug carriers, EVs play crucial roles in intercellular communication by delivering essential cell-specific information to target cells. This review summarizes the roles of EVs secreted by various cell types and involved in various biological processes in the pathogenesis, diagnosis, and treatment of DR.

FRONTIERS IN ENDOCRINOLOGY (2023)

Add to Collection

Review Biotechnology & Applied Microbiology

Engineered extracellular vesicles: potentials in cancer combination therapy

Jiangbin Chen, Qi Tan, Zimo Yang, Yang Jin

Summary: Extracellular vesicles (EVs) are secretory vesicles with cell-derived membrane and contents, which can be designed as drug delivery platforms for cancer therapy due to their cargo delivery capability. With biocompatibility and immune compatibility, EVs have unique advantages compared with other nanocarriers. Engineered EVs can be modified to achieve desired performance and have potential for various combinations of cancer treatment methods. Application of engineered EVs in cancer therapy is shifting towards combinational therapy to combat heterogeneous cancer cells and complex tumor microenvironment, highlighting the need for more effective treatment plans in the future.

JOURNAL OF NANOBIOTECHNOLOGY (2022)

Add to Collection

Review Cell Biology

From Mesenchymal Stromal Cells to Engineered Extracellular Vesicles: A New Therapeutic Paradigm

Jancy Johnson, Mozhgan Shojaee, James Mitchell Crow, Ramin Khanabdali

Summary: MSCs, as a leading cell source for stem cell therapy, have regenerative and immunomodulatory properties, but face challenges in clinical applications. EVs and EEVs, as potential cell-free alternatives, may overcome these challenges in the clinical application of MSCs.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Review Cell Biology

Insight into Extracellular Vesicle-Cell Communication: From Cell Recognition to Intracellular Fate

Lana Ginini, Salem Billan, Eran Fridman, Ziv Gil

Summary: Extracellular vesicles (EVs) are crucial heterogenous lipid structures secreted by cells for cell-to-cell communication. EVs primarily enter cells through endocytosis, a process that may depend on proteins and lipids on the surfaces of both vesicles and target cells.

CELLS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Extracellular Vesicle Proteome in Prostate Cancer: A Comparative Analysis of Mass Spectrometry Studies

Rui Miguel Marques Bernardino, Ricardo Leao, Rui Henrique, Luis Campos Pinheiro, Prashant Kumar, Prashanth Suravajhala, Hans Christian Beck, Ana Sofia Carvalho, Rune Matthiesen

Summary: The study explores possible strategies for urinary biomarker discovery, especially focused on proteome of urine EVs for PCa. Through reanalysis of proteomics data and network analysis, the findings suggest that urinary EVs may provide potential biomarkers with higher protein coverage compared to other sample sources and may fully characterize the heterogeneity of PCa.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Chromatographic Scalable Method to Isolate Engineered Extracellular Vesicles Derived from Mesenchymal Stem Cells for the Treatment of Liver Fibrosis in Mice

Luciana M. M. Dominguez, Barbara Bueloni, Ma. Jose Cantero, Milagros Albornoz, Natalia Pacienza, Celeste Biani, Carlos Luzzani, Santiago Miriuka, Mariana Garcia, Catalina Atorrasagasti, Gustavo Yannarelli, Juan Bayo, Esteban Fiore, Guillermo Mazzolini

Summary: Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) have been shown to have similar phenotype and antifibrotic activity when isolated from adipose tissue MSCs, induced-pluripotent-stem-cell-derived MSCs, and umbilical cord perivascular cells (HUCPVC) using ion exchange chromatography. EVs derived from AdhIGF-I-HUCPVC carried IGF-1 and exhibited a higher therapeutic effect in vitro and in vivo. This scalable manufacturing strategy of MSC-derived EVs holds promise as a therapeutic tool for liver fibrosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Oncology

The value of hsa_circ_0058514 in plasma extracellular vesicles for breast cancer

Jiani Liu, Xinyu Peng, Yang Yang, Yao Zhang, Meng Han, Xiaohui Shi, Jie Zheng, Tong Li, Jinxia Chen, Weihua Lv, Yunjiang Liu, Yixin Qi, Lei Zhang, Qi Liu

Summary: The study found that hsa_circ_0058514 can serve as an early plasma biomarker for breast cancer diagnosis with better diagnostic value than conventional tumor markers. It is also a predictor for the efficacy of neoadjuvant chemotherapy. Additionally, the expression level of hsa_circ_0058514 is associated with clinicopathological characteristics in breast cancer patients.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Diagnosis potential of subarachnoid hemorrhage using miRNA signatures isolated from plasma-derived extracellular vesicles

Bin Sheng, Niansheng Lai, Tao Tao, Xiangxin Chen, Sen Gao, Qi Zhu, Wei Li, Qingrong Zhang, Chunhua Hang

Summary: This study characterized plasma extracellular vesicles in patients with aSAH using microRNAs (miRNAs) as diagnostic tools. Next-generation sequencing identified four differentially expressed miRNAs, which were validated in a large cohort. The results showed that miR-369-3p, miR-410-3p, miR-193b-3p, and miR-486-3p could predict the neurological outcomes of aSAH patients and have potential clinical utility as prognostic biomarkers.

FRONTIERS IN PHARMACOLOGY (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Exosomes and Other Extracellular Vesicles with High Therapeutic Potential: Their Applications in Oncology, Neurology, and Dermatology

Urszula Szwedowicz, Zofia Lapinska, Agnieszka Gajewska-Naryniecka, Anna Choromanska

Summary: Until 30 years ago, extracellular vesicles (EVs) were believed to be used for removing unnecessary compounds from cells. However, their enormous potential for diagnosing and treating diseases has now been recognized. EVs play a crucial role in intercellular communication by transferring bioactive molecules between cells. Compared to lab-created drug nanocarriers, EVs are more stable in physiological conditions and have lower immunogenicity and cytotoxicity. EVs can deliver cargo to specific cells due to their membrane proteins and lipids. New strategies have been developed to create tailor-made therapeutic EVs. However, there are significant challenges in applying EVs as drug-delivery agents in clinical settings.

MOLECULES (2022)

Add to Collection

Article Chemistry, Analytical

Signal amplification strategies in biosensing of extracellular vesicles (EVs)

Sedighe Khaksari, Khalil Abnous, Farzin Hadizadeh, Mohammad Ramezani, Seyed Mohammad Taghdisi, Seyed Ali Mousavi Shaegh

Summary: Extracellular vesicles (EVs) are membrane-enclosed vesicles secreted from mammalian cells, which act as multi-component delivery vehicles for intercellular communications. Probing circulating EVs has great potential for early diagnostics of diseases, and biosensors have attracted attention in the identification of EVs due to their simplicity and portability. Amplification strategies, including various detection modalities and microfluidic systems, are essential for detecting the extremely low concentrations of EVs in bodily fluids at early stages of a disease.

TALANTA (2023)

Add to Collection

Review Cell Biology

Plant-derived extracellular vesicles: a novel nanomedicine approach with advantages and challenges

Mohadeseh Nemati, Bipin Singh, Rakeeb Ahmad Mir, Mahdieh Nemati, Azadeh Babaei, Mahdi Ahmadi, Yousef Rasmi, Afsaneh Gholinejad Golezani, Jafar Rezaie

Summary: Plant-derived extracellular vesicles (P-EVs) have multiple functions in plant physiology and can be isolated from various plant species. P-EVs have potential applications in cell-free therapy and drug-delivery systems, but clinical translation faces challenges.

CELL COMMUNICATION AND SIGNALING (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity

Anat Aharon, Ayelet Dangot, Fadi Kinaani, Mor Zavaro, Lian Bannon, Tali Bar-lev, Anat Keren-Politansky, Irit Avivi, Giris Jacob

Summary: This study aimed to determine whether coagulation profiles and extracellular vesicles (EVs) could serve as markers for COVID-19 severity. Testing was done on 36 patients with mild/moderate/severe disease and 16 healthy individuals. The results showed that EVs, but not coagulation profiles, may serve as biomarkers for COVID-19 severity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Endocrinology & Metabolism

Oviductal extracellular vesicles from women with endometriosis impair embryo development

Yuehan Li, Lei Cai, Na Guo, Chang Liu, Meng Wang, Lixia Zhu, Fei Li, Lei Jin, Cong Sui

Summary: This study aimed to investigate the influence of oviductal extracellular vesicles (oEV) from patients with endometriosis on early embryo development. In vitro experiments were conducted using human oEV and murine embryos. The results showed that oEV from endometriosis patients significantly decreased blastocyst rates and down-regulated oxidative phosphorylation in blastocysts. Additionally, embryos cultured with oEV from endometriosis patients exhibited increased oxidative stress and apoptosis levels. Overall, oEV from patients with endometriosis negatively affect early embryo development by interfering with oxidative phosphorylation.

FRONTIERS IN ENDOCRINOLOGY (2023)

Add to Collection

Article Hematology

Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Guillermo Orti, Luuk Gras, Nienke Zinger, Maria Chiara Finazzi, Katja Sockel, Marie Robin, Edouard Forcade, Daniele Avenoso, Nicolaus Kroeger, Juergen Finke, Aleksandar Radujkovic, Mathilde Hunault-Berger, Wilfried Schroyens, Tsila Zuckerman, Jean Henri Bourhis, Yves Chalandon, Adrian Bloor, Rik Schots, Liesbeth C. de Wreede, Joana Drozd-Sokolowska, Kavita Raj, Nicola Polverelli, Tomasz Czerw, Juan Carlos Hernandez-Boluda, Donal McLornan, Ibrahim Yakoub-Agha

Summary: Allogeneic hematopoietic cell transplant (allo-HCT) is the only potential route to long-term remission for patients with blast phase transformation of myeloproliferative neoplasm (BP-MPN). A large retrospective registry-based study showed that the 3-year overall survival (OS) of BP-MPN patients undergoing allo-HCT was 36%. Factors associated with lower OS included Karnofsky Performance Score < 90 and active disease at allo-HCT, while more recent allo-HCT was associated with higher OS.

AMERICAN JOURNAL OF HEMATOLOGY (2023)

Add to Collection

Review Oncology

High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review

Eugenia Accorsi Buttini, Mirko Farina, Luisa Lorenzi, Nicola Polverelli, Vera Radici, Enrico Morello, Federica Colnaghi, Camillo Almici, Emilio Ferrari, Andrea Bianchetti, Alessandro Leoni, Federica Re, Katia Bosio, Simona Bernardi, Michele Malagola, Alessandro Re, Domenico Russo

Summary: CAR T-cell therapy can cause hematological toxicity and may lead to the development of MDS, which may be related to previous chemotherapy and immune suppression. A multicenter prospective study is needed to further investigate the underlying causes of cytopenia after CAR T-cell treatment and the presence of secondary myeloid malignancies.

FRONTIERS IN ONCOLOGY (2023)

Add to Collection

Article Oncology

Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome

Francesca Palandri, Massimo Breccia, Camilla Mazzoni, Giuseppe Auteri, Elena Maria Elli, Malgorzata M. M. Trawinska, Nicola Polverelli, Mario Tiribelli, Giulia Benevolo, Alessandra Iurlo, Alessia Tieghi, Florian H. H. Heidel, Giovanni Caocci, Eloise Beggiato, Gianni Binotto, Francesco Cavazzini, Maurizio Miglino, Costanza Bosi, Monica Crugnola, Monica Bocchia, Bruno Martino, Novella Pugliese, Mattia Biondo, Marta Venturi, Luigi Scaffidi, Alessandro Isidori, Daniele Cattaneo, Mauro Krampera, Fabrizio Pane, Daniela Cilloni, Gianpietro Semenzato, Roberto M. M. Lemoli, Antonio Cuneo, Elisabetta Abruzzese, Daniela Bartoletti, Simona Paglia, Nicola Vianelli, Michele Cavo, Massimiliano Bonifacio, Giuseppe A. A. Palumbo

Summary: This study explored the prognostic factors of cytopenic myelofibrosis (MF) and found that high molecular risk mutations, intermediate 2/high Dynamic International Prognostic Score System, and intermediate 2/high Myelofibrosis Secondary to Polycythemia Vera and Essential Thrombocythemia Prognostic Model were associated with cytopenic MF. Patients with cytopenia received lower doses of ruxolitinib and had worse treatment outcomes, suggesting the need for alternative therapeutic strategies.

CANCER (2023)

Add to Collection

Letter Oncology

Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib

Francesca Palandri, Elena M. Elli, Giuseppe Auteri, Massimiliano Bonifacio, Giulia Benevolo, Florian H. Heidel, Simona Paglia, Malgorzata M. Trawinska, Costanza Bosi, Elena Rossi, Mario Tiribelli, Alessia Tieghi, Alessandra Iurlo, Nicola Polverelli, Giovanni Caocci, Gianni Binotto, Francesco Cavazzini, Eloise Beggiato, Daniela Cilloni, Caterina Tatarelli, Francesco Mendicino, Maurizio Miglino, Monica Bocchia, Monica Crugnola, Camilla Mazzoni, Andrea D. Romagnoli, Giovanni Rindone, Sara Ceglie, Alessandra D'Addio, Eleonora Santoni, Daniele Cattaneo, Daniela Bartoletti, Roberto M. Lemoli, Mauro Krampera, Antonio Cuneo, Gianpietro C. Semenzato, Roberto Latagliata, Elisabetta Abruzzese, Nicola Vianelli, Michele Cavo, Alessandro Andriani, Valerio De Stefano, Giuseppe A. Palumbo, Massimo Breccia

BLOOD CANCER JOURNAL (2023)

Add to Collection

Article Oncology

Bone marrow CD34+molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia

Michele Malagola, Nicola Polverelli, Alessandra Beghin, Federica Bolda, Marta Comini, Mirko Farina, Enrico Morello, Vera Radici, Eugenia Accorsi Buttini, Simona Bernardi, Federica Re, Alessandro Leoni, Davide Bonometti, Duilio Brugnoni, Arnalda Lanfranchi, Domenico Russo

Summary: We retrospectively analyzed the impact of bone marrow CD34+ molecular chimerism and WT1 on the outcome of AML patients submitted to allogeneic stem cell transplantation. The cumulative incidence of relapse was significantly lower in patients with high donor chimerism on CD34+ cells and low WT1 levels at 1st and 3rd month post-transplantation. By combining chimerism and WT1 at 3rd month, patients with intermediate prognosis could be identified.

FRONTIERS IN ONCOLOGY (2023)

Add to Collection

Letter Biophysics

CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation

Michele Malagola, Vera Radici, Mirko Farina, Simone Pellizzeri, Filippo Spoldi, Enrico Morello, Nicola Polverelli, Eugenia Accorsi Buttini, Simona Bernardi, Federica Re, Alessandro Leoni, Liana Signorini, Arnaldo Caruso, Domenico Russo

BONE MARROW TRANSPLANTATION (2023)

Add to Collection

Article Oncology

A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis

Francesca Palandri, Giuseppe A. Palumbo, Massimiliano Bonifacio, Elena M. Elli, Mario Tiribelli, Giuseppe Auteri, Malgorzata M. Trawinska, Nicola Polverelli, Giulia Benevolo, Alessia Tieghi, Fabrizio Cavalca, Giovanni Caocci, Eloise Beggiato, Gianni Binotto, Francesco Cavazzini, Maurizio Miglino, Costanza Bosi, Monica Crugnola, Monica Bocchia, Bruno Martino, Novella Pugliese, Marta Venturi, Alessandro Isidori, Daniele Cattaneo, Mauro Krampera, Fabrizio Pane, Daniela Cilloni, Gianpietro Semenzato, Roberto M. Lemoli, Antonio Cuneo, Elisabetta Abruzzese, Filippo Branzanti, Nicola Vianelli, Michele Cavo, Florian Heidel, Alessandra Iurlo, Massimo Breccia

Summary: Predictors of early discontinuation of ruxolitinib therapy and death on therapy were investigated in patients with myelofibrosis. Low platelet and hemoglobin levels, primary myelofibrosis, no spleen response at 3 months, and low starting dose of ruxolitinib were associated with a higher probability of therapy failure. A predictive model was built to identify patients at higher risk of failure with ruxolitinib monotherapy, who should consider alternative frontline strategies.

CANCERS (2023)

Add to Collection

Article Oncology

Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR)

Elisabetta Abruzzese, Monica Bocchia, Malgorzata Monika Trawinska, Donatella Raspadori, Francesco Bondanini, Anna Sicuranza, Paola Pacelli, Federica Re, Alessia Cavalleri, Mirko Farina, Michele Malagola, Domenico Russo, Paolo De Fabritiis, Simona Bernardi

Summary: The monitoring of minimal residual disease (MRD) in Chronic Myeloid Leukemia (CML) is crucial for treatment response assessment and selection of the best responders. This pilot study compared the gold standard RT-qPCR method with digital PCR and flow cytometry for MRD detection. It was found that digital PCR and flow cytometry had higher sensitivity than RT-qPCR and could detect MRD in samples previously undetectable. Additionally, low-level MRD was associated with successful treatment discontinuation.

CANCERS (2023)

Add to Collection

Article Immunology

Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation

Enrico Morello, Giulia Brambilla, Simona Bernardi, Vincenzo Villanacci, Michela Carlessi, Mirko Farina, Vera Radici, Emanuela Samarani, Simone Pellizzeri, Nicola Polverelli, Alessandro Leoni, Marco Andreoli, Francesco Arena, Chiara Ricci, Michele Malagola, Domenico Russo

Summary: Malnutrition is a common issue in allo-SCT and is associated with poor outcomes. This study suggests that supplementing with TGF-FSMP can reduce malnutrition and improve post-transplant outcomes, as well as decrease the incidence of complications such as aGVHD and pneumonia.

TRANSPLANT IMMUNOLOGY (2023)

Add to Collection

Review Hematology

Digital PCR as a New Method for Minimal Residual Disease Monitoring and Treatment Free Remission Management in Chronic Myeloid Leukemia Patients: Is It Reliable?

Simona Bernardi, Michele Malagola, Mirko Farina, Nicola Polverelli, Federica Re, Domenico Russo

Summary: The effective monitoring of Minimal Residual Disease or Measurable Residual Disease (MRD) is crucial for the management of hematologic malignancies, especially in Chronic Myeloid Leukemia (CML) patients. The recent application of digital PCR in CML patients monitoring has shown to improve the accuracy and precision in identifying optimal responders.

HEMATO (2023)

Add to Collection

No Data Available

dsDNA from extracellular vesicles (EVs) in adult AML

Journal

Publisher

SPRINGER

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper